RAC 3.79% $1.53 race oncology ltd

"Given how far Lederle were able to take bisantrene, and how we...

  1. 1,243 Posts.
    lightbulb Created with Sketch. 242
    "Given how far Lederle were able to take bisantrene, and how we have been able to solve the problem that prevented them commercialisating bisantrene, it could be argued that the chance of success is much higher than 30%."

    So what range would you suggest? You can respond as Davisite maybe?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.